Abstract 4302: Next-generation STING mRNA therapy with reduced toxicity and dual action against cancer by boosting immunity and inducing tumor cell death
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Hanmi Pharmaceutical (South Korea)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148767795
Cites:
Cited by:
Related to: